The effect of self-management training program on self-efficacy of disease management and quality of life of patients with scleroderma

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230715058789N1

Enrollment

Registered

2023-09-30

Start date

2023-09-16

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleroderma. Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention 1: Intervention group: The intervention is in 6 sessions of 60-75 minutes (self-management) and each session includes three parts reviewing the educational content presented in the previo

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of scleroderma disease based on classification indices of the American University of Rheumatology and its evaluation and confirmation by a rheumatologist Age equal to or greater than 18 years Ability to communicate in Farsi Non-diagnosis of mental disorders based on the statement of the patient and family No use of psychoactive drugs in the last three months Ability to answer questions Failure to participate in any self-management or rehabilitation program within the past three months More than one year has passed since the disease

Exclusion criteria

Exclusion criteria: Scleroderma patients hospitalized in wards Simultaneously suffering from other musculoskeletal diseases such as lupus, rheumatoid arthritis, Behcet's syndrome, etc.

Design outcomes

Primary

Measure	Time frame
The self-efficacy of disease management score in the Self-Efficacy for Managing Chronic Disease questionnaire. Timepoint: Before the start of the intervention, after the end of the intervention and three months after the end of the intervention. Method of measurement: Self-Efficacy for Managing Chronic Disease Questionnaire.;The quality of life score in the Systemic Sclerosis Quality of Life Questionnaire. Timepoint: Before the start of the intervention, after the end of the intervention and three months after the end of the intervention. Method of measurement: Systemic Sclerosis Quality of Life Questionnaire.	—

Measure

Time frame

The self-efficacy of disease management score in the Self-Efficacy for Managing Chronic Disease questionnaire. Timepoint: Before the start of the intervention, after the end of the intervention and three months after the end of the intervention. Method of measurement: Self-Efficacy for Managing Chronic Disease Questionnaire.;The quality of life score in the Systemic Sclerosis Quality of Life Questionnaire. Timepoint: Before the start of the intervention, after the end of the intervention and three months after the end of the intervention. Method of measurement: Systemic Sclerosis Quality of Life Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Sadegh Hallaj

Ahvaz University of Medical Sciences

hallaj.ms@ajums.ac.ir+98 61 3314 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026